Dapiprazole Hydrochloride

CHEMBL1201044 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
361.9 g/mol
LogP
Phase
4

The hydrochloride salt form of dapiprazole, used in ophthalmic preparations to reverse drug-induced pupil dilation. It blocks alpha-adrenergic receptors in the iris to allow the pupil-constricting muscles to work. This salt form is used in the commercially available eye drop formulation.

Peso molecular

361,9000 g/mol

TPSA

37,20 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1.Cl

InChI

InChI=1S/C19H27N5.ClH/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19;/h2-3,6-7H,4-5,8-15H2,1H3;1H

Molecular Formula

C19H28ClN5

HBD / HBA

1 / 4

Enlaces Rotables

4

Átomos Pesados

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The hydrochloride salt form of dapiprazole, used in ophthalmic preparations to reverse drug-induced pupil dilation. It blocks alpha-adrenergic receptors in the iris to allow the pupil-constricting muscles to work. This salt form is used in the commercially available eye drop formulation.

Yes, Dapiprazole Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201044. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6917787. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.